[go: up one dir, main page]

KR20120049634A - Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis - Google Patents

Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis Download PDF

Info

Publication number
KR20120049634A
KR20120049634A KR1020100110992A KR20100110992A KR20120049634A KR 20120049634 A KR20120049634 A KR 20120049634A KR 1020100110992 A KR1020100110992 A KR 1020100110992A KR 20100110992 A KR20100110992 A KR 20100110992A KR 20120049634 A KR20120049634 A KR 20120049634A
Authority
KR
South Korea
Prior art keywords
sunscreen
necrosis
evaluating
cell death
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020100110992A
Other languages
Korean (ko)
Inventor
김형준
이명렬
오택진
김광미
이종석
박창훈
김한곤
노민수
신동욱
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020100110992A priority Critical patent/KR20120049634A/en
Publication of KR20120049634A publication Critical patent/KR20120049634A/en
Ceased legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE: A method for evaluating efficiency of UV protector is provided to measure cell apoptosis rate and to accurately protect UV ray. CONSTITUTION: A method for evaluating efficiency of UV protector comprises: a step of applying an UV protector onto UV permeable material; a step of irradiating UV onto the upper portion of the UV permeable material; and a step of measuring cell death of skin cells. The UV permeable material is a quartz plate or band pass filter. The skin cells include keratinocytes, fibroblasts, or melanocytes. The cell death includes apoptosis and necrosis.

Description

세포사멸율을 측정하여 자외선차단제의 효능을 평가하는 방법{Method for evaluating the effectiveness of UV screening agents by measuring the rate of cell apoptosis and necrosis}Method for evaluating the effectiveness of UV screening agents by measuring the rate of cell apoptosis and necrosis}

본 발명은 자외선차단제의 효능을 평가하는 방법에 관한 것으로, 보다 상세하게는 자외선차단제를 UV 투과성 물질에 도포하는 단계; 피부 세포를 상기 UV 투과성 물질 하부에 위치시킨 후 UV 투과성 물질 상부에 UV를 조사하는 단계; 및 상기 피부 세포를 수득하여 세포 사멸율을 측정하는 단계를 포함하는 자외선차단제의 효능을 평가하는 방법에 관한 것이다.
The present invention relates to a method for evaluating the efficacy of a sunscreen, and more particularly, applying a sunscreen to a UV-transmitting material; Placing skin cells under the UV permeable material and then irradiating UV over the UV permeable material; And it relates to a method for evaluating the efficacy of the sunscreen comprising the step of obtaining the skin cells to measure the cell death rate.

현재 모든 자외선차단제(Sunscreen)의 효능평가는 "SPF(sun protection factor)"라 명명되는 UVB 영역(290?320 nm)이 유도하는 홍반(erythema), 및 "PA (Protection of UVA)"로 명명되는 UVA 영역(320?400 nm)이 유도하는 흑화(Persistent Pigment Darkening) 현상을 실험자의 육안평가를 통해 제품의 자외선 차단력을 평가하고 있다. Efficacy evaluation of all sunscreens at present is called erythema induced by UVB region (290-320 nm) called "sun protection factor" and "Protection of UVA" (PA). Persistent Pigment Darkening induced by the UVA region (320-400 nm) is evaluated through the naked eye evaluation of the product to evaluate the UV blocking ability of the product.

그러나, 자외선차단제를 투과한 광원이 홍반, 흑화와 같은 현상은 일으키지 않으나 피부에 영향을 주는 정도는 다르며 이를 평가할 수 있는 방법이 없기에 새로운 평가방법 이 절실히 요구되는 상황이다.However, the light source transmitted through the sunscreen does not cause phenomena such as erythema and blackening, but the degree of affect on the skin is different and there is no method for evaluating a new evaluation method.

이에 본 발명자들은 SPF나 PA의 차단력을 나타내는 수치가 동일한 것에 대해서도 세포의 자가사멸(Apoptosis) 또는 괴사(Necrosis)를 유발하는 정도가 다르게 나타나는 것을 확인하고, 세포의 자가사멸 또는 괴사에 의한 세포사멸율을 측정함으로써 자외선차단제의 효능을 정확하고 세부적으로 측정할 수 있음을 발견하고 본 발명을 완성하게 되었다.Accordingly, the present inventors confirmed that the degree of inducing apoptosis or necrosis of the cells is different even when the values indicating the blocking ability of SPF or PA are the same, and the rate of cell death due to cell death or necrosis is different. The present invention was completed by discovering that the effect of the sunscreen can be measured accurately and in detail.

따라서, 본 발명의 목적은 SPF나 PA의 차단력을 나타내는 수치가 동일한 자외선차단제에서도 그 효능의 차이를 정확하게 식별할 수 있는 자외선차단제의 효능 평가방법을 제공하는 것이다.
Accordingly, it is an object of the present invention to provide a method for evaluating the efficacy of a sunscreen that can accurately identify the difference in efficacy even with a sunscreen having the same value indicating the blocking ability of SPF or PA.

상기한 목적을 달성하기 위하여, 본 발명에서는 자외선차단제를 UV 투과성 물질에 도포하는 단계; 피부 세포를 상기 UV 투과성 물질 하부에 위치시킨 후 UV 투과성 물질 상부에 UV를 조사하는 단계; 및 상기 피부 세포를 수득하여 세포 사멸율을 측정하는 단계를 포함하는 자외선차단제의 효능 평가방법을 제공한다.In order to achieve the above object, the present invention comprises the steps of applying a sunscreen to the UV-transmitting material; Placing skin cells under the UV permeable material and then irradiating UV over the UV permeable material; And it provides a method for evaluating the efficacy of the sunscreen comprising the step of obtaining the skin cells to measure the cell death rate.

본 발명에서는 피부세포에서의 세포사멸율을 측정함으로써 피부에 대한 자외선차단제의 효과를 더욱 세분화하여 정확하고 신뢰도 높은 자외선차단 효과를 평가할 수 있었다.
In the present invention, by measuring the cell death rate in the skin cells it was possible to further subdivide the effect of the sunscreen on the skin to evaluate the accurate and reliable sunscreen effect.

도 1 은 유사 혹은 동일 SPF 임상지수의 투과율(Sunscreen Transmittance) 차이를 보여주는 그래프이다.
도 2는 Annexin V 와 P.I 염색(staining) 공동자극 분자(costimulatory molecule)의 검출량(%)에 의한 세포 자가사멸 및 괴사의 정도의 도식화한 것이다.
도 3a 내지 3g는 비교예 1?2 및 실시예 1?5의 유사 혹은 동일 임상지수 자외선차단제의 세포 자가사멸율 및 괴사율을 측정한 결과이다.
FIG. 1 is a graph showing the difference in the Sunscreen Transmittance of similar or identical SPF clinical index.
Figure 2 is a schematic of the degree of cell self-killing and necrosis by the amount of detection (%) of Annexin V and PI staining costimulatory molecules.
Figures 3a to 3g is a result of measuring the cell death rate and necrosis rate of the similar or identical clinical index sunscreen of Comparative Examples 1-2 and Examples 1-5.

본 발명에서는 기존의 인체를 포함한 인공피부 및 실험동물 등에서 단순히 태양광의 투과량 또는 투과방지 효능을 보거나 홍반이나 흑화의 육안평가를 통해 SPF나 PA를 측정하는 방법이 피부에 미치는 영향을 정확히 대변하기에 부족한 점을 보완하기 위하여, SPF나 PA의 차단력을 나타내는 수치가 동일한 것에 대해서도 세포의 자가사멸 또는 괴사를 유발하는 정도는 다르다는 것을 증명하였고, 이를 통해 자외선차단제의 효능을 평가할 수 있는 새로운 평가방법을 제공할 수 있었다.
In the present invention, it is insufficient to accurately represent the effect on the skin of the method of measuring SPF or PA through the visual evaluation of erythema or blackening simply by seeing the amount of sunlight penetration or prevention of penetration in artificial skin and laboratory animals including the existing human body. In order to supplement the above, it was proved that the degree of inducing cell death or necrosis is different even for the same values indicating the blocking ability of SPF or PA, thereby providing a new evaluation method to evaluate the efficacy of sunscreen. Could.

본 발명에서는 하기 단계를 포함하는 자외선차단제의 효능 평가방법을 제공한다:The present invention provides a method for evaluating the efficacy of a sunscreen comprising the following steps:

자외선차단제를 UV 투과성 물질에 도포하는 단계; Applying a sunscreen to the UV transmissive material;

피부 세포를 상기 UV 투과성 물질 하부에 위치시킨 후 UV 투과성 물질 상부에 UV를 조사하는 단계; 및 Placing skin cells under the UV permeable material and then irradiating UV over the UV permeable material; And

상기 피부 세포를 수득하여 세포 사멸율을 측정하는 단계.
Obtaining the skin cells to measure cell death rate.

상기에서, UV 투과성 물질은 UV를 투과시키면서 자외선차단제의 도포가 가능한물성을 지닌 것이면 모두 사용이 가능하며, 예를 들면 석영판(Quartz Plate) 또는 목표로 하는 광선영역만 투과시키는 대역(帶域)통과필터(Band pass filter) 등을 사용할 수 있으나, 이에만 한정되는 것은 아니다.In the above, the UV-transmitting material can be used as long as the UV-transmitting material has a property that can be applied to the sunscreen while transmitting UV, for example, a quartz plate or a band for transmitting only a target ray region. A band pass filter may be used, but the present invention is not limited thereto.

상기 피부세포는 인간 또는 동물 유래 피부 세포를 모두 사용할 수 있으며, 예를 들면, 각질분화형성세포(Keratinocytes), 섬유아세포(fibroblast) 또는 멜라닌형성세포(Melanocytes) 등을 사용할 수 있으나, 이에만 한정되는 것은 아니다.The skin cells may be used both human or animal-derived skin cells, for example, keratinocytes, fibroblasts or melanocytes, etc., but are not limited thereto. It is not.

상기 세포사멸율은 UV 조사에 의한 세포의 자가사멸 또는 괴사 비율을 측정하여 산출할 수 있다. 이때, 상기 세포의 자가사멸 또는 괴사는 육안평가를 통한 세포의 모양변화, MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, MTT) 분석법, WST-1 분석법, 요오드화 프로피디엄(P.I: Propidium iodide) 분석법 및 관련단백질 및 유전자를 보는 방법 등 여러 가지가 있겠으나 바람직하게는 항체 및 염색법을 통한 유세포분석(flow cytometry)으로 평가하는 것이 더욱 바람직하다. 상기 WST-1 분석법은 테트라졸리움 염(Tetrazolium salt (WST-1))에서 포마잔(formazan) 색소로 변화하는 원리를 이용하여 세포 증식 능력이나 세포 생존 능력을 알 수 있는 Premix WST-1 세포 성장 분석법이며, MTT 분석법은 살아있는 세포에서 물에 녹지 않는 포마잔결정(formazan crystal)으로 환원되는 노란색 테트라졸리움 염으로부터 형성된 색소의 색상을 분석하는 방법이며, 요오드화 프로피디엄 분석법은 요오드화 프로피디엄이 손상된 세포막에 침투하여 세포 내 DNA와 결합하여 밝은 적색을 발하는 원리를 이용하여 염색된 세포를 측정하는 방법이다.The apoptosis rate can be calculated by measuring the rate of self-killing or necrosis of cells by UV irradiation. At this time, the self-killing or necrosis of the cells changes the shape of the cells through visual evaluation, MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide, MTT) assay, WST-1 There may be various methods, such as assays, Propidium iodide (PI) assays, and methods of viewing related proteins and genes, but it is more preferable to evaluate them by flow cytometry through antibodies and staining. The WST-1 assay is a Premix WST-1 cell growth assay that can determine cell proliferation ability or cell viability using the principle of changing from tetrazolium salt (WST-1) to formazan pigment. The MTT assay is a method for analyzing the color of a pigment formed from a yellow tetrazolium salt which is reduced to a formazan crystal insoluble in living cells, and the iodide propidium assay is a damaged iodide propidium. It is a method of measuring the stained cells using the principle of penetrating the cell membrane and binding to the intracellular DNA to give a bright red color.

본 발명에서 사용하는 평가 대상 물질은 자외선차단제 이외에 화장품과 같이 사람의 피부에 적용하는 제품이나 제형 등에 구성성분으로 적용하고자 하는 모든 물질을 대상으로 할 수 있다.
The substance to be evaluated in the present invention may be any substance to be applied as a constituent to products or formulations applied to human skin, such as cosmetics, in addition to sunscreen.

이하, 본 발명의 내용을 실시예 및 시험예를 통하여 보다 구체적으로 설명한다. 이들 실시예는 본 발명의 내용을 이해하기 위해 제시되는 것일 뿐 본 발명의 권리범위가 이들 실시예 및 시험예로 한정되는 것은 아니고, 당업계에서 통상적으로 주지된 변형, 치환 및 삽입 등을 수행할 수 있으며, 이에 대한 것도 본 발명의 범위에 포함된다.
Hereinafter, the present invention will be described more specifically with reference to examples and test examples. These examples are provided only for understanding the contents of the present invention, but the scope of the present invention is not limited to these examples and test examples, and modifications, substitutions, and insertions commonly known in the art may be performed. It may be included in the scope of the present invention.

[실시예 1?5] 자외선차단제 제조Example 1 to 5 Preparation of sunscreen

하기 표 1에 기재된 성분을 갖는 자외선차단제를 통상적인 방법으로 제조하였다(단위: 중량%).A sunscreen having the components shown in Table 1 below was prepared in a conventional manner (unit: wt%).

성분ingredient 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 실시예 5Example 5 TiO2 TiO 2 1.11.1 22 8.88.8 3.43.4 1.41.4 ZnOZnO 2.82.8 1212 88 -- -- OMC(octyl methoxy cinnamate)Octyl methoxy cinnamate (OMC) 77 7.57.5 -- 33 55 이소아밀 p-메톡시신나메이트
(Isoamyl p-Methoxycinnamate)
Isoamyl p-methoxycinnamate
(Isoamyl p-Methoxycinnamate)
22 -- -- -- 22
에틸헥실 살리실레이트
(Ethylhexyl Salicylate)
Ethylhexyl salicylate
(Ethylhexyl Salicylate)
4.54.5 -- -- -- --
티노소브 S(Tinosorb S)Tinosorb S 33 33 -- 66 33 옥토크릴렌(Octocrylene)Octocrylene  -- 22 -- -- -- 폴리실리콘-15(Polysilicone-15)Polysilicone-15 -- 1One -- -- --

[시험예 1][Test Example 1]

실시예 1?5에서 제조한 자외선차단제의 SPF 및 PA 임상지수, 및 자외선차단제 투과율을 각각 조사하였으며, 그 결과를 하기 표 2 및 도 1에 각각 나타내었다. 이때, 자외선차단제의 투과율은 2 mg/㎠의 양을 대역통과필터 위에 도포한 후, 분광광도계(Spectrophotometer)인 SPF-290S 자외선차단제 분석 시스템(Sunscreen Analyzer System)으로 측정하였다.SPF and PA clinical index, and sunscreen transmittance of the sunscreen prepared in Examples 1 to 5 were investigated, respectively, and the results are shown in Table 2 and FIG. 1, respectively. At this time, the transmittance of the sunscreen was applied to the bandpass filter in an amount of 2 mg / ㎠, and then measured with a spectrophotometer SPF-290S sunscreen analyzer system (Sunscreen Analyzer System).

유사 혹은 동일 SPF 및 PA 임상지수Similar or identical SPF and PA clinical index 시험물질Test substance SPFSPF PAPA 실시예 1Example 1 54 54 ++++++ 실시예 2Example 2 52 52 ++++++ 실시예 3Example 3 5757 ++++++ 실시예 4Example 4 54 54 ++++++ 실시예 5Example 5 35 35 ++ ++

상기 표 2 및 도 1의 결과에서, 실시예 1?5의 자외선차단제는 모두 유사 혹은 동일한 범주의 SPF 및 PA 임상지수, 및 투과율을 나타내었다.
In the results of Table 2 and FIG. 1, the sunscreen agents of Examples 1 to 5 all exhibited SPF and PA clinical indexes and transmittances of similar or identical categories.

[시험예 2] 세포사멸율 측정Test Example 2 Measurement of Apoptosis

본 발명에 사용된 사람정상각질피부세포는 상용적으로 확보되어 권장하는 방법으로, 론자사(Lonza, Inc. 미국 메릴랜드주 워커스빌(Walkersville) 소재)에서 구입하여 사용하였다.Human normal keratin skin cells used in the present invention was commercially secured and recommended, and purchased from Lonza, Inc., Walkersville, Maryland.

상기의 세포를 계대 배양한 후 CO2 항온배양기(CO2 incubator)에서 37℃, 5% CO2 조건하에서 세포를 배양하였다. 세포 배양액은 론자사의 지침서에 따라 배양하였다. 500 ml의 KBM-2(Clonetics CC-3103) 배지에 KGM-2 불렛 키트(Bullet kit: BPE(Bovine pituitary extract) 2 ml, hEGF(human epidermal growth factor) 0.5 ml, 인슐린(Insulin) 0.5 ml, 하이드로코티손(Hydrocortisone) 0.5 ml, 트랜스페린(Transferrin) 0.5 ml, 에피네프린(Epinephrine) 0.5 ml 및 젠타마이신 설페이트+암포페리신-B(Gentamycin Suflate + Amphofericin-B: GA-1000) 0.5 ml를 첨가하여 사용하였다.After subculture the cells were cultured in a cell under a CO 2 constant temperature incubator (CO 2 incubator) at 37 ℃, 5% CO 2 condition. Cell cultures were cultured according to Lonza's instructions. In 500 ml of KBM-2 (Clonetics CC-3103) medium, KGM-2 Bullet Kit (Bullet kit: 2 ml of Bovine pituitary extract (BPE), 0.5 ml of human epidermal growth factor (hEGF), 0.5 ml of insulin (Insulin), hydro 0.5 ml of Cortison (Hydrocortisone), 0.5 ml of Transferrin, 0.5 ml of Epinephrine and 0.5 ml of Gentamycin Sulfate + Amphofericin-B (Gentamycin Suflate + Amphofericin-B: GA-1000) were used.

실시예 1?5의 자외선차단제를 대역통과필터 위에 도포한 후 그 하부에 사람정상각질피부세포(Human epidermal neonatal keratinocyte cells)를 위치시킨 다음, 자외선차단제가 도포된 부위의 위쪽에서 광원(UVB 및 UVA)을 조사(50 MED, 1MED = 21 mJ/㎠)한 다음 그 아래 위치시켰던 세포를 수득하여 세포의 자가사멸율 및 괴사율을 측정하였다. 비교예 1은 UV를 처리하지 않은 세포이고, 비교예 2는 상기 자외선차단제를 처리하지 않고 UV를 조사한 세포이다.After applying the sunscreen of Examples 1-5 on the bandpass filter, human epidermal neonatal keratinocyte cells were placed on the bottom, and then the light source (UVB and UVA) was applied above the sunscreen. ) Was irradiated (50 MED, 1MED = 21 mJ / ㎠), and then the cells placed below were obtained to measure the rate of cell death and necrosis. Comparative Example 1 is a cell not treated with UV, and Comparative Example 2 is a cell irradiated with UV without treating the sunscreen.

상기에서 수득한 세포를 인산완충액(PBS)으로 세척한 후 FITC로 형광표지한 항-Annexin V-FITC 항체(Sigma)를 이용하여 4℃에서 30분간 염색한 다음 인산완충액으로 1 μg 요오드화 프로피디엄(P.I; Sigma)으로 4℃에서 30분간 염색시킨 후 위와 같은 방법으로 세포를 세척하였다. 세척한 세포를 유세포분석기(Flow cytometry)로 형광강도를 측정하여 세포에서 발현되는 Annexin V 와 P.I 염색(staining) 공동자극 분자의 검출량(%)을 측정하여 세포자가사멸(Apoptosis) 및 세포괴사(Necrosis) 정도를 알아보았으며, 그 결과를 도 3a 내지 3g에 도시하였다. 이때, 도 3a 내지 3g에 표기된 용어들의 의미는 다음과 같다:The cells obtained above were washed with phosphate buffer (PBS) and stained for 30 minutes at 4 ° C. using an anti-Annexin V-FITC antibody (Sigma) fluorescently labeled with FITC, followed by 1 μg iodide propidium with phosphate buffer. After staining at 4 ° C. for 30 minutes with (PI; Sigma), cells were washed in the same manner as above. The fluorescence intensity of the washed cells was measured by flow cytometry to measure the detection amount (%) of Annexin V and PI staining costimulatory molecules expressed in the cells, thereby apoptosis and necrosis. ), And the results are shown in FIGS. 3A to 3G. In this case, the meanings of the terms indicated in FIGS. 3A to 3G are as follows:

- FSC-H(Forward light scatter): 세포 또는 입자의 크기와 관련된 척도Forward light scatter (FSC-H): A measure related to the size of a cell or particle.

- SSCH(Side light scatter): 세포 또는 입자 안의 내부구조 및 입도(granularity)에 관련된 척도Side light scatter (SSCH): A measure of the internal structure and granularity of a cell or particle.

- FL1-H(fluorescence 1): 유세포분석기(Flow cytometer)에서 감지할 수 있는 여러 파장의 형광 중, 그린(green)에 해당하는 형광으로서, FITC 및 CFSE 등의 형광염료가 이 파장의 빛을 낸다. -FL1-H (fluorescence 1): Among the fluorescence of various wavelengths that can be detected by flow cytometer, fluorescence corresponding to green, fluorescent dyes such as FITC and CFSE emit light of this wavelength .

- FL3-H(fluorescence 3): 유세포분석기에서 감지할 수 있는 여러 파장의 형광 중, 레드(red)에 해당하는 형광으로서, 요오드화 프로피듐 및 텍사스레드(texas red) 등이 이 파장의 빛을 낸다(H는 큰 의미가 없는 표식이다).-FL3-H (fluorescence 3): Among the fluorescence of various wavelengths that can be detected by flow cytometer, fluorescence corresponding to red, propidium iodide and texas red emit light of this wavelength. (H is an insignificant mark).

- 결과분석의 예: 세포자가사멸 단계에 있는 세포들의 경우, 안에 자가소화 입상(granule)이 증가하고 세포 자체는 작아지기 때문에 FSC 값은 작아지고 SSC 값은 커진다.
Example of result analysis: For cells in the apoptotic phase, the FSC value becomes smaller and the SSC value increases because the granule inside and the cell itself become smaller.

도 3a 내지 3g의 결과에서, 유사 혹은 동일한 범주의 SPF 및 PA 임상지수, 및 투과율을 보였던 실시예 1?5의 자외선차단제 처리군들의 세포사멸율이 모두 다르게 측정되는 것을 확인할 수 있었다.In the results of FIGS. 3A to 3G, it was confirmed that SPF and PA clinical indexes of similar or identical categories, and apoptosis rates of the sunscreen treatment groups of Examples 1 to 5, which showed transmittance, were all measured differently.

Claims (4)

자외선차단제를 UV 투과성 물질에 도포하는 단계;
피부 세포를 상기 UV 투과성 물질 하부에 위치시킨 후 UV 투과성 물질 상부에 UV를 조사하는 단계; 및
상기 피부 세포를 수득하여 세포 사멸율을 측정하는 단계를 포함하는 자외선차단제의 효능 평가방법.
Applying a sunscreen to the UV transmissive material;
Placing skin cells under the UV permeable material and then irradiating UV over the UV permeable material; And
Efficacy evaluation method of the sunscreen comprising the step of obtaining the skin cells to measure the cell death rate.
제 1항에 있어서, 상기 UV 투과성 물질은 석영판(Quartz Plate) 또는 대역(帶域)통과필터(Band pass filter)인 것을 특징으로 하는 자외선차단제의 효능 평가방법.The method of claim 1, wherein the UV-transmitting material is a quartz plate or a band pass filter. 제 1항에 있어서, 상기 피부 세포는 각질분화형성세포(Keratinocytes), 섬유아세포(fibroblast) 또는 멜라닌형성세포(Melanocytes)인 것을 특징으로 하는 자외선차단제의 효능 평가방법.According to claim 1, wherein the skin cells are keratinocyte (Keratinocytes), fibroblasts (fibroblast) or melanocytes (Melanocytes) method for evaluating the efficacy of the sunscreen. 제 1항에 있어서, 상기 세포 사멸율은 세포의 자가사멸 또는 괴사에 의한 것임을 특징으로 하는 자외선차단제의 효능 평가방법.The method of claim 1, wherein the cell death rate is due to cell death or necrosis.
KR1020100110992A 2010-11-09 2010-11-09 Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis Ceased KR20120049634A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100110992A KR20120049634A (en) 2010-11-09 2010-11-09 Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100110992A KR20120049634A (en) 2010-11-09 2010-11-09 Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis

Publications (1)

Publication Number Publication Date
KR20120049634A true KR20120049634A (en) 2012-05-17

Family

ID=46267384

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100110992A Ceased KR20120049634A (en) 2010-11-09 2010-11-09 Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis

Country Status (1)

Country Link
KR (1) KR20120049634A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012112819A1 (en) 2012-05-10 2013-11-14 Lg Display Co., Ltd. LIGHT PANEL AND THIS USING LIQUID CRYSTAL DISPLAY DEVICE
KR20150007545A (en) 2013-07-11 2015-01-21 한국생명공학연구원 Method and device for measurement for cell viability
KR20150064579A (en) * 2013-12-03 2015-06-11 (주)아모레퍼시픽 Method for screening of sunlight protection functional material and method for evaluating sunlight protection effect
KR20200038591A (en) 2018-10-04 2020-04-14 (주)아모레퍼시픽 Method for evaluating sun protection degree
CN119530335A (en) * 2025-01-22 2025-02-28 天津诺卡生物医药科技有限公司 A method for evaluating the sunscreen function of cosmetics and cosmetic raw materials and its application

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012112819A1 (en) 2012-05-10 2013-11-14 Lg Display Co., Ltd. LIGHT PANEL AND THIS USING LIQUID CRYSTAL DISPLAY DEVICE
KR20150007545A (en) 2013-07-11 2015-01-21 한국생명공학연구원 Method and device for measurement for cell viability
KR20150064579A (en) * 2013-12-03 2015-06-11 (주)아모레퍼시픽 Method for screening of sunlight protection functional material and method for evaluating sunlight protection effect
KR20200038591A (en) 2018-10-04 2020-04-14 (주)아모레퍼시픽 Method for evaluating sun protection degree
CN119530335A (en) * 2025-01-22 2025-02-28 天津诺卡生物医药科技有限公司 A method for evaluating the sunscreen function of cosmetics and cosmetic raw materials and its application

Similar Documents

Publication Publication Date Title
US12290374B2 (en) System and method for testing the effects of ultraviolet and visible light on skin
Opländer et al. Effects of blue light irradiation on human dermal fibroblasts
CN113646000A (en) cell activator
JP4286309B2 (en) Method for determining an integrated solar protection factor wrapping UVA and UVB radiation
KR20120049634A (en) Method for evaluating the effectiveness of uv screening agents by measuring the rate of cell apoptosis and necrosis
Wang et al. Ex vivo evaluation of radical sun protection factor in popular sunscreens with antioxidants
WO2014152096A1 (en) In vitro determination of sunscreen protection based on image analysis of sunscreens applied to skin
Pescia et al. On the assessment of photostability of sunscreens exposed to UVA irradiation: from glass plates to pig/human skin, which is best?
CN112544571B (en) Establishment and application of the Caenorhabditis elegans model for evaluating the safety and efficacy of sunscreens
EP3751254B1 (en) Method for evaluating protective effect against external damage to skin
Parwaiz et al. Recent developments in tuning the efficacy of different types of sunscreens
KR20120059672A (en) Method for evaluating the sunscreen effect by measuring the specific gene expression
Nomura et al. Exponential attenuation of light along nonlinear path through the biological model
JP2020522546A (en) Skin care application of extracellular metabolites derived from Bacillus coagulans
US20060133996A1 (en) Method and apparatus for determining effectiveness of sunscreens and other skin preparations in shielding human skin from uva radiation
CN109152726A (en) Mitigate the adverse effects of sunlight with ingredients obtained from living plants
CN111511289B (en) Judgment method of UV sensitivity
Zingler et al. Biological evaluation of enamel sealants in an organotypic model of the human gingiva
KR20170012565A (en) Composition
KR102131041B1 (en) Method for screening of sunlight protection functional material and method for evaluating sunlight protection effect
BUCKLEY et al. Reflection spectrophotometry: III. Absorption characteristics and color of human skin
Hesterberg et al. Raman spectroscopic analysis of the carotenoid concentration in egg yolks depending on the feeding and housing conditions of the laying hens
Rodriguez et al. Effects of ultraviolet radiation on human cutaneous nerve fibres
JP2023003406A (en) Evaluation method for sustained oxidative stress and immediate blackening by upe measurement
JP2012159381A (en) Photoinhibition evaluation device and method for measuring photoinhibition rate of test substance

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20101109

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20151102

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20101109

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160919

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20170112

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20160919

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20170112

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20161117

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20170313

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170208

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20170112

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20161117

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20160919